FDA Approves Unknown Drug — PHARM ASSOC

On April 18, 2008, Pharm Assoc received approval for their ANDA submission (040834), paving the way for the potential entry of a new generic drug into the market under the generic-specific designation of N/A. This clearance stimulates a shift in market dynamics by establishing competition against the reference-listed product, which is anticipated to impact industry pricing and erode existing market share.